During the past decade, Ntouch Research Corporation conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ntouch Research Corporation" #1 sponsor was "Abbott" with 3 trials, followed by "Sanofi" with 2 trials sponsored, "Boehringer Ingelheim" with 1 trials sponsored, "Daiichi Sankyo, Inc." with 1 trials sponsored and "Emergent Product Development Seattle LLC" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "Ntouch Research Corporation" are "Prostatic Neoplasms" (2 trials), "Benign Prostatic Hypertrophy" (1 trials), "Chronic Bronchitis" (1 trials), "Chronic Obstructive Pulmonary Disease" (1 trials) and "Emphysema" (1 trials). Many other conditions were trialed in "Ntouch Research Corporation" in a lesser frequency.

Most popular intervention types in "Ntouch Research Corporation" are "Drug" (9 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atrasentan" (3 trials), "ABPM" (1 trials), "Alfuzosin (SL770499)" (1 trials), "HuMax-CD4" (1 trials) and "Losartan & Hydrochlorothiazide" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ntouch Research Corporation" are 5 trials for "All" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Ntouch Research Corporation". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Ntouch Research Corporation, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ntouch Research Corporation, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".